Fundraising FoxByorna
1 known investors
Find your way into Byorna
Sign up to see every warm intro you have to Byorna
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Byorna team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Byorna develops a bioproduction platform that uses eukaryotic cell biofactories to manufacture high-quality messenger RNA (mRNA) at lower cost, isolating the mRNA in cellular subcompartments for extraction and GMP-grade production. Its technology targets mRNA-based therapeutics including vaccines for infectious diseases, cancer treatments, and RNA gene therapy for rare diseases.</parameter> <parameter name="founders">[]
Founders & leadership
P
Pascal
Investors · 1
Frequently asked questions
- What does Byorna do?
- Byorna develops a bioproduction platform that uses eukaryotic cell biofactories to manufacture high-quality messenger RNA (mRNA) at lower cost, isolating the mRNA in cellular subcompartments for extraction and GMP-grade production. Its technology targets mRNA-based therapeutics including vaccines for infectious diseases, cancer treatments, and RNA gene therapy for rare diseases.</parameter> <parameter name="founders">[]
- Who founded Byorna?
- Byorna was founded by Pascal.
- Who are Byorna's investors?
- Byorna's investors include Polytechnique Ventures.